Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Protection Against Embolism for Non-valvular AF Subjects: Investigational Device Evaluation of the WATCHMAN FLX™ LAA Closure Technology

NCT02702271 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.

NCT NCT02702271
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02702271 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Protection Against Embolism for Non-valvular AF Subjects: Investigational Device Evaluation of the WATCHMAN FLX™ LAA Closure Technology
Lead sponsor
Boston Scientific Corporation
Phase
Not applicable
Overall status
Completed
Start date
May 7, 2018
Completion date
March 12, 2021
Enrollment
458 (actual)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation